NHS Dudley Health Economy Medicines Formulary
Home > 10 Musculoskeletal and joint diseases > 10.1 Drugs used in rheumatic diseases and gout > 10.1.3 Drugs that suppress the rheumatic disease process > Psoriatic arthritis - golimumab - NICE TAG TA220

Psoriatic arthritis - golimumab - NICE TAG TA220

1.1 Golimumab is recommended as an option for the treatment of active and progressive psoriatic arthritis in adults only if:

1.2 When using the Psoriatic Arthritis Response Criteria (PsARC; as set out in NICE technology appraisal guidance 199), healthcare professionals should take into account any physical, sensory or learning disabilities, or communication difficulties that could affect a person's responses to components of the PsARC and make any adjustments they consider appropriate.


Site by Devopa
© Copyright 2022 NHS. All rights reserved.